Christopherson KW[au] - Search Results

Year	Number of Results
1980	1
1982	1
2001	1
2002	3
2003	4
2004	2
2006	3
2007	3
2008	1
2009	1
2010	1
2011	3
2012	6
2013	2
2024	0

1

Endothelial chemokines in autoimmune disease.

Christopherson KW 2nd, Hromas RA. Christopherson KW 2nd, et al. Curr Pharm Des. 2004;10(2):145-54. doi: 10.2174/1381612043453405. Curr Pharm Des. 2004. PMID: 14754394 Review.

2

Liver X receptor alpha (LXRalpha) as a therapeutic target in chronic lymphocytic leukemia (CLL).

Christopherson KW 2nd, Landay A. Christopherson KW 2nd, et al. J Leukoc Biol. 2009 Nov;86(5):1019-21. doi: 10.1189/jlb.0509295. J Leukoc Biol. 2009. PMID: 19875628 Free PMC article. No abstract available.

3

PBSCs Sphingoling along S1P/S1P1 axis.

Christopherson KW 2nd. Christopherson KW 2nd. Blood. 2012 Jan 19;119(3):645-6. doi: 10.1182/blood-2011-11-391250. Blood. 2012. PMID: 22262738 Free article. No abstract available.

4

Retinopathy in juvenile-onset diabetes of short duration.

Frank RN, Hoffman WH, Podgor MJ, Joondeph HC, Lewis RA, Margherio RR, Nachazel DP Jr, Weiss H, Christopherson KW, Cronin MA. Frank RN, et al. Among authors: christopherson kw. Ophthalmology. 1980 Jan;87(1):1-9. doi: 10.1016/s0161-6420(80)35282-2. Ophthalmology. 1980. PMID: 7375082

5

Cellular therapies supplement: strategies for improving transplant efficiency in the context of cellular therapeutics.

Jimenez A, Fung HC, Christopherson KW 2nd. Jimenez A, et al. Among authors: christopherson kw 2nd. Transfusion. 2011 Nov;51 Suppl 4:125S-137S. doi: 10.1111/j.1537-2995.2011.03375.x. Transfusion. 2011. PMID: 22074623

6

Aggressive disease defined by cytogenetics is associated with cytokine dysregulation in CLL/SLL patients.

Karmali R, Paganessi LA, Frank RR, Jagan S, Larson ML, Venugopal P, Gregory SA, Christopherson KW 2nd. Karmali R, et al. Among authors: christopherson kw 2nd. J Leukoc Biol. 2013 Jan;93(1):161-70. doi: 10.1189/jlb.0612301. Epub 2012 Nov 7. J Leukoc Biol. 2013. PMID: 23136257 Free PMC article.

7

Modulation of hematopoietic stem cell homing and engraftment by CD26.

Christopherson KW 2nd, Hangoc G, Mantel CR, Broxmeyer HE. Christopherson KW 2nd, et al. Science. 2004 Aug 13;305(5686):1000-3. doi: 10.1126/science.1097071. Science. 2004. PMID: 15310902

8

Low-molecular-weight heparins inhibit CCL21-induced T cell adhesion and migration.

Christopherson KW 2nd, Campbell JJ, Travers JB, Hromas RA. Christopherson KW 2nd, et al. J Pharmacol Exp Ther. 2002 Jul;302(1):290-5. doi: 10.1124/jpet.302.1.290. J Pharmacol Exp Ther. 2002. PMID: 12065729

9

Endothelial induction of the T-cell chemokine CCL21 in T-cell autoimmune diseases.

Christopherson KW 2nd, Hood AF, Travers JB, Ramsey H, Hromas RA. Christopherson KW 2nd, et al. Blood. 2003 Feb 1;101(3):801-6. doi: 10.1182/blood-2002-05-1586. Epub 2002 Sep 26. Blood. 2003. PMID: 12393410 Free article.

10

Transgenic overexpression of the CC chemokine CCL21 disrupts T-cell migration.

Christopherson KW 2nd, Campbell JJ, Hromas RA. Christopherson KW 2nd, et al. Blood. 2001 Dec 15;98(13):3562-8. doi: 10.1182/blood.v98.13.3562. Blood. 2001. PMID: 11739157 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

27 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year